

NCT01959425 comparison:

Summary:
CHIA has 26 criteria while your personal folder has 26 criteria
Total found criteria: 26/26
Total not Found: 0/26
Total Extra: 2
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Successful cardiac ablation for AF                 │ Successful cardiac ablation for AF                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Documented freedom from AF recurrence (symptomatic │ Documented freedom from AF recurrence (symptomatic │
│ or asymptomatic arrhythmic recurrences lasting     │ or asymptomatic arrhythmic recurrences lasting     │
│ longer than 30 seconds) 3 months after successful  │ longer than 30 seconds) 3 months after successful  │
│ cardiac ablation (AF recurrence during 3-month     │ cardiac ablation (AF recurrence during 3-month     │
│ blanking period is excluded)                       │ blanking period is excluded)                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient must have been on a commercially approved  │ Patient must have been on a commercially approved  │
│ anticoagulation therapy for at least two (2)       │ anticoagulation therapy for at least two (2)       │
│ months prior to randomization in the OAT Study     │ months prior to randomization in the OAT Study     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ CHADS2 score = 2 or CHA2DS2-VASc score (=3)        │ CHADS2 score ≥ 2 or CHA2DS2-VASc score (≥3)        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Left ventricular ejection fraction > 25%           │ Left ventricular ejection fraction \> 25%          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ LA size < 65                                       │ LA size \< 65                                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ High risk for thromboembolic events (i.e., CHADS2  │ High risk for thromboembolic events (i.e., CHADS2  │
│ score = 2 or CHA2DS2-VASc score = 3) and require   │ score ≥ 2 or CHA2DS2-VASc score ≥ 3) and require   │
│ OAT before undergoing cardiac ablation             │ OAT before undergoing cardiac ablation             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Able and willing to comply with all pre- and       │ Able and willing to comply with all pre- and       │
│ follow-up testing and requirements                 │ follow-up testing and requirements                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Signed informed consent form                       │ Signed informed consent form                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Age 18 years or older                              │ Age 18 years or older                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ OAT required for reasons not related to AF (i.e.,  │ OAT required for reasons not related to AF (i.e.,  │
│ prosthetic valve, PV stenosis, previous pulmonary  │ prosthetic valve, PV stenosis, previous pulmonary  │
│ embolism, presence of spontaneous echo contrast    │ embolism, presence of spontaneous echo contrast    │
│ [SEC] at standard echo performed at 3-months       │ \[SEC\] at standard echo performed at 3-months     │
│ follow-up)                                         │ follow-up)                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Any cardiac surgery within the past 60 days (2     │ Any cardiac surgery within the past 60 days (2     │
│ months) or valvular cardiac surgical procedure at  │ months) or valvular cardiac surgical procedure at  │
│ any time (i.e., ventriculotomy, atriotomy, and     │ any time (i.e., ventriculotomy, atriotomy, and     │
│ valve repair or replacement and presence of a      │ valve repair or replacement and presence of a      │
│ prosthetic valve)                                  │ prosthetic valve)                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Previous myocardial infarction (MI) or a           │ Previous myocardial infarction (MI) or a           │
│ percutaneous coronary intervention PCI within the  │ percutaneous coronary intervention PCI within the  │
│ past 3 months                                      │ past 3 months                                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Awaiting cardiac transplantation or other cardiac  │ Awaiting cardiac transplantation or other cardiac  │
│ surgery within the next 365 days (12 months)       │ surgery within the next 365 days (12 months)       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Documented left atrial thrombus                    │ Documented left atrial thrombus                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Significant pulmonary disease, (e.g., restrictive  │ Significant pulmonary disease, (e.g., restrictive  │
│ pulmonary disease, constrictive or COPD) or any    │ pulmonary disease, constrictive or COPD) or any    │
│ other disease or malfunction of the lungs or       │ other disease or malfunction of the lungs or       │
│ respiratory system that produces chronic symptoms  │ respiratory system that produces chronic symptoms  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Significant medical problem that in the opinion of │ Significant medical problem that in the opinion of │
│ the investigator would preclude enrollment in this │ the investigator would preclude enrollment in this │
│ study                                              │ study                                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Women who are pregnant (as evidenced by pregnancy  │ Women who are pregnant (as evidenced by pregnancy  │
│ test if pre-menopausal)                            │ test if pre-menopausal)                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Acute illness or active systemic infection or      │ Acute illness or active systemic infection or      │
│ sepsis                                             │ sepsis                                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Unstable angina                                    │ Unstable angina                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Contraindication to anticoagulation (i.e.,         │ Contraindication to anticoagulation (i.e.,         │
│ heparin, warfarin or another commercially          │ heparin, warfarin or another commercially          │
│ available anticoagulation medication)              │ available anticoagulation medication)              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of blood clotting or bleeding              │ History of blood clotting or bleeding              │
│ abnormalities                                      │ abnormalities                                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Life expectancy less than 360 days (12 months)     │ Life expectancy less than 360 days (12 months)     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Uncontrolled Heart Failure or NYHA Class III or IV │ Uncontrolled Heart Failure or NYHA Class III or IV │
│ heart failure                                      │ heart failure                                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Enrollment in a clinical study evaluating another  │ Enrollment in a clinical study evaluating another  │
│ device or drug, within the past 6 months           │ device or drug, within the past 6 months           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Unable or unwilling to comply with protocol        │ Unable or unwilling to comply with protocol        │
│ requirements                                       │ requirements                                       │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have minimum age of 18 Years │
├───────────────────────────────────┤
│ Must have maximum age of 90 Years │
╘═══════════════════════════════════╛